IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survival
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survival
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 15, Issue 4, Pages 469-479
Publisher
Oxford University Press (OUP)
Online
2013-02-14
DOI
10.1093/neuonc/nos317
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IDH mutation impairs histone demethylation and results in a block to cell differentiation
- (2012) Chao Lu et al. NATURE
- IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
- (2012) Sevin Turcan et al. NATURE
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
- (2011) Wei Xu et al. CANCER CELL
- IDH1 and IDH2 mutations, immunohistochemistry and associations in a series of brain tumors
- (2011) Marta Mellai et al. JOURNAL OF NEURO-ONCOLOGY
- Molecular Classification of Low-Grade Diffuse Gliomas
- (2010) Young-Ho Kim et al. AMERICAN JOURNAL OF PATHOLOGY
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
- (2010) Houtan Noushmehr et al. CANCER CELL
- A Pyrosequencing-Based Assay for the Rapid Detection of IDH1 Mutations in Clinical Samples
- (2010) Prashanth Setty et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Primer extension based quantitative polymerase chain reaction reveals consistent differences in the methylation status of the MGMT promoter in diffusely infiltrating gliomas (WHO grade II–IV) of adults
- (2010) Erik Vassella et al. JOURNAL OF NEURO-ONCOLOGY
- IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
- (2010) C. Houillier et al. NEUROLOGY
- Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
- (2009) Christian Hartmann et al. ACTA NEUROPATHOLOGICA
- IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas
- (2009) Takuya Watanabe et al. AMERICAN JOURNAL OF PATHOLOGY
- miR-15a and miR-16 Are Implicated in Cell Cycle Regulation in a Rb-Dependent Manner and Are Frequently Deleted or Down-regulated in Non–Small Cell Lung Cancer
- (2009) Nora Bandi et al. CANCER RESEARCH
- Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
- (2009) Marc Sanson et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide
- (2009) H. J. Dubbink et al. NEUROLOGY
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oligodendrogliomas: Molecular Biology and Treatment
- (2009) J. E. C. Bromberg et al. ONCOLOGIST
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search